1 follower
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pat... Read more
Joel Lewis
Madrigal Pharmaceuticals
2 followers
Mirum Pharmaceuticals
3 followers
Lisata Therapeutics
1 follower
Bristol-Myers Squibb
209 followers
Walgreens Boots Alliance
112 followers
VIRIXENE
123 followers
Viatris
38 followers
Lundbeck
38 followers
Syneos Health
23 followers
Alnylam Pharmaceuticals
23 followers
Parexel
9 followers
Explore companies